Lupus

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vilá, L M
Right arrow Articles by Vilá, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vilá, L M
Right arrow Articles by Vilá, S
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Lupus, Vol. 15, No. 12, 892-898 (2006)
DOI: 10.1177/0961203306069352

Clinical and prognostic value of autoantibodies in Puerto Ricans with systemic lupus erythematosus

L M Vilá

Department of Internal Medicine, Division of Rheumatology, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico, lvila{at}rcm.upr.edu

M J Molina

Department of Internal Medicine, Division of Rheumatology, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico

A M Mayor

Department of Medicine, Univesidad Central del Caribe School of Medicine, Bayamón, Puerto Rico

R A Peredo

Department of Internal Medicine, Division of Rheumatology, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico

M L Santaella

Department of Internal Medicine, Division of Rheumatology, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico

S Vilá

Department of Internal Medicine, Division of Rheumatology, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico

The aim of this study was to determine the association between lupus autoantibodies and the clinical manifestations and outcome in a cohort of Puerto Ricans patients with systemic lupus erythematosus (SLE). All patients fulfilled the American College of Rheumatology classification criteria for SLE. Demographic parameters, clinical manifestations over time and damage accrual were obtained at the last study visit. Disease damage was assessed with the Systemic Lupus International Collaborating Clinics Damage Index (SDI). ANA, ANA pattern, and anti-dsDNA, anti-Smith, anti-Ro (SSA), anti-La (SSB) and anti-snRNP antibodies were measured at the time of SLE diagnosis. Chi-square test, Fisher exact test, ANOVA, logistic regression and general lineal model analyses were used to evaluate these associations. Ninety-six percent of patients were females. The cohort had a mean age of 40.2 = 12.0 years and mean disease duration of 9.6 = 7.0 years. Patients with elevated anti-dsDNA antibodies were more likely to have vasculitis, pericardial effusion, renal involvement, anaemia, leukopenia, lymphopenia and thrombocytopenia. Anti-Smith antibodies were positively associated with skin ulcerations, elevated liver enzymes, renal involvement and thrombocytopenia. Anti-Ro antibodies were related with the presence of discoid lupus, serositis, pneumonitis, elevated liver enzymes, hemolytic anaemia, leukopenia and lymphopenia. No positive associations were found for anti-snRNP or anti-La antibodies. The presence of anti-dsDNA, anti-Smith and anti-Ro antibodies was associated with higher SDI scores. In conclusion, anti-dsDNA, anti-Smith and anti-Ro antibodies are associated with several clinical manifestations and more damage accrual in Puerto Ricans with SLE. These findings provide valuable clinical and prognostic information for this ethnic population.

Key Words: autoantibodies • clinical manifestations • clinical outcome • disease damage • Puerto Ricans • systemic lupus erythematosus

References

  • Reveille JD. Predictive value of autoantibodies for activity of systemic lupus erythematosus . Lupus 2004; 13: 290-297 .[Abstract/Free Full Text]
  • Mills JA. Systemic lupus erythematosus . N Engl J Med 1994; 330: 1871-1879 .[Free Full Text]
  • Yee CS, Hussein H, Skan J, Bowman S, Situnayake D, Gordon C. Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus . Rheumatology 2003; 42: 276-279 .[Abstract/Free Full Text]
  • Pisetsky DS. Anti-DNA and autoantibodies . Curr Opin Rheum 2000; 12: 364-368 .[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • López-Longo FJ, Monteagudo I, Gonzalez CM, Grau R, Carrero L. Systemic lupus erythematosus: clinical expression and anti-Ro/SSA response in patients with and without lesions of subacute cutaneous lupus erythematosus . Lupus 1997; 6: 32-39 .[ISI][Medline] [Order article via Infotrieve]
  • Saurit V, Campana R, Ruiz Lascano Aet al. Mucocutaneous lesions in patients with systemic lupus erythematosus . Medicina 2003; 63: 283-287 .
  • Reichlin M. Serological correlations with nephritis in systemic lupus erythematosus . Clin Immunol 2005; 117: 12-14 .[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Düzgün N, Hoier-Madsen M, Wiik A, Tokgöz G. The frequency of autoantibodies in Turkish patients with lupus nephritis . Rheumatol Int 1997; 17: 1-4 .[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • García CO, Molina JM, Gutiérrez-Urueña Set al. Autoantibody profile in African-American patients with lupus nephritis . Lupus 1996; 5: 602-605 .[ISI][Medline] [Order article via Infotrieve]
  • Mitjavila F, Pac V, Moga Iet al. Clinicopathological correlations and prognostic factors in lupus nephritis . Clin Exp Rheumatol 1997; 15: 625-631 .[ISI][Medline] [Order article via Infotrieve]
  • Barr SG, Petri M. Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus . Arthritis Rheum 2001; 44: 2342-2349 .[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Sulcebe G, Morcka K. Diagnostic and prognostic significance of different antinuclear antibodies in more than 1000 consecutive Albanian patients with rheumatic diseases . Clin Exp Rheumatol 1992; 10: 255-261 .[ISI][Medline] [Order article via Infotrieve]
  • Zandman-Goddard G, Gilburd B, Shovman Oet al. The homogeneous multiplexed system-a new method for autoantibody profile in systemic lupus erythematosus . Clin Dev Immunol 2005; 12: 107-111 .[CrossRef][Medline] [Order article via Infotrieve]
  • Molina JM, Molina J, García C, Gharavi AE, Wilson WA, Espinosa LR. Ethnic differences in the clinical expression of systemic lupus erythematosus: A comparative study between African-American and Latin Americans . Lupus 1997; 6: 63-67 .[ISI][Medline] [Order article via Infotrieve]
  • Vilá LM, Alarcón GS, McGwin G Jret al. for the LUMINA Study Group. Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations . Rheumatology (Oxford) 2004; 43: 358-363 .[Medline] [Order article via Infotrieve]
  • Houman MH, Smiti-Khanfir M, Ben Ghorbell I, Miled M. Systemic lupus erythematosus in Tunisia: demographic and clinical analysis of 100 patients . Lupus 2004; 13: 204-211 .[Abstract/Free Full Text]
  • Vilá LM, Mayor AM, Valentín AH, García-Soberal M, Vilá S. Clinical and immunological manifestations in 134 Puerto Rican patients with systemic lupus erythematosus . Lupus 1999; 8: 279-286 .[Abstract/Free Full Text]
  • Tan EM, Cohen AS, Fries JFet al. The 1982 revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum 1982; 25: 1271-1277 .[ISI][Medline] [Order article via Infotrieve]
  • Cervera R, Kamashta MA, Font Jet al. Systemic lupus erythematosus: clinical and immunological patterns of disease expression in a cohort of 1,000 patients . Medicine 1993; 72: 113-124 .[Medline] [Order article via Infotrieve]
  • Stoll T, Stucki G, Malik J, Pyke S, Isenberg DA. Association of the Systemic Lupus Erythematosus International Collaborating Clinics/American College of Rheumatology Damage Index with systemic lupus erythematosus . J Rheumatol 1997; 24: 309-313 .[ISI][Medline] [Order article via Infotrieve]
  • Linnik MD, Hu JZ, Heilbrunn KR, Strand V, Hurley FL, Joh T and the LJP 394 Investigator Consortium. Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus . Arthritis Rheum 2005; 52: 1129-1137 .[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Alba P, Bento L, Cuadrado MJet al. Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis . Ann Rheum Dis 2003; 62: 556-560 .[Abstract/Free Full Text]
  • Witte T, Hartung K, Matthias Tet al. Association of IgA anti-dsDNA antibodies with vasculitis and disease activity in systemic lupus erythematosus. SLE Study Group . Rheumatol Int 1998; 18: 63-69 .[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Colburn KK, Green LM, Wong AK. Circulation antibodies to guanosine in systemic lupus erythematosus: correlation with nephritis and polyserositis by acute and longitudinal analysis . Lupus 2001; 10: 410-417 .[Abstract/Free Full Text]
  • Chien JW, Lin CY, Yang LY. Correlation between anti-Ro/La titers and clinical findings of patients with systemic lupus erythematosus . Zhonghua Yi Xue Za Zhi 2001; 64: 283-291 .[Medline] [Order article via Infotrieve]
  • Sultan SM, Begum S, Isenberg DA. Prevalence, patterns of disease and outcome in patients with systemic lupus erythematosus who develop severe haematological problems . Rheumatology 2003; 42: 230-234 .[Abstract/Free Full Text]
  • Homma M, Mimori T, Takeda Yet al. Autoantibodies to the Sm antigen immunological approach to clinical aspects of systemic lupus erythematosus . J Rheumatol 1987; 14: 188-193 .
  • Gregorio GV, Davies ET, Mieli-Vergani G, Vergani D. Significance of extractable nuclear antigens in childhood autoimmune liver disease . Clin Exp Immunol 1995; 102: 308-313 .[ISI][Medline] [Order article via Infotrieve]
  • Pradhan VD, Badakere SS, Bichile LS, Dolas MP. Antibodies to Ro/SS-A and La/SS-B in systemic lupus erythematosus and other autoimmune disorders . J Assoc Physicians India 2002; 50: 762-765 .[Medline] [Order article via Infotrieve]
  • Fritzler MJ, Kinsella TD. The CREST syndrome: a distinct serologic entity with anticentromere antibodies . Am J Med 1980; 69: 520-526 .[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Synkowski DR, Reichlin M, Provost TT. Serum autoantibodies in systemic lupus erythematosus and correlation with cutaneous features . J Rheumatol 1982; 9: 380-385 .[ISI][Medline] [Order article via Infotrieve]
  • Ioannides D, Golden BD, Buyon JP, Bystryn JC. Expression of SS-A/Ro and SS-B/La antigens in skin biopsy specimens of patients with photosensitivity forms of lupus erythematosus . Arch Dermatol 2000; 136: 340-346 .[Abstract/Free Full Text]
  • Sutej PG, Gear AJ, Morrison RCet al. Photosensitivity and anti-Ro (SS-A) antibodies in black patients with systemic lupus erythematosus (SLE) . Br J Rheumatol 1989; 28: 321-324 .[Abstract/Free Full Text]
  • Boulware DW, Hedgpeth MT. Lupus pneumonitis and anti-SSA (Ro) antibodies . J Rheumatol 1989; 16: 479-481 .[ISI][Medline] [Order article via Infotrieve]
  • Inoue T, Okamura M, Negoro Net al. Anti-Ro/SS-A antibody-positive interstitial pneumonitis in a non-lupus patient . Osaka City Med J 1994; 40: 117-120 .[Medline] [Order article via Infotrieve]
  • Hedgpeth MT, Boulware DW. Interstitial pneumonitis in antinuclear antibody-negative systemic lupus erythematosus: a new clinical manifestation and possible association with anti-Ro (SS-A) antibodies . Arthritis Rheum 1988; 31: 545-548 .[ISI][Medline] [Order article via Infotrieve]
  • Erbey F, Cuhaci A, Incecik Fet al. Neonatal lupus erythematosus presenting with cholestatic hepatitis: a case report and review of the literature . Turk J Pediatr 2005; 47: 63-66 .[ISI][Medline] [Order article via Infotrieve]
  • Zuppa AA, Delogu AB, De Rosa Get al. Neonatal lupus: different clinical neonatal expression in siblings . Arch Pediatr 2004; 11: 936-939 .[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Besson-Leaud L, Fontan D, Billeaud C, Sandler B. Neonatal lupus erythematosus and neurologic involvement: an incident association? Arch Pediatr 2002; 9: 503-505 .[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Weston WL, Morelli JG, Lee LA. The clinical spectrum of anti-Ro-positive cutaneous neonatal lupus erythematosus . J Am Acad Dermatol 1999; 40: 675-681 .[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Devesa IJ, Ferrando Ginestar J, Bustamante Balen Met al. Autoimmune hepatitis and anti-Ro antibodies. Is there a link? Gastroenterol Hepatol 2003; 26: 475-479 .[CrossRef][Medline] [Order article via Infotrieve]
  • Zonana-Nacach A, Camargo-Coronel A, Yanez Pet al. Measurement of damage in 210 Mexican patients with systemic lupus erythematosus: relationship with disease duration . Lupus 1998; 7: 119-123 .[Abstract/Free Full Text]
  • Ruiz-Irastorza G, Egurbide MV, Martinez-Berriotxoa A, Ugalde J, Aguirre C. Antiphospholipid antibodies predict early damage in patients with systemic lupus erythematosus . Lupus 2004; 13: 900-905 .[Abstract/Free Full Text]
  • Soares M, Reis L, Papi JA, Cardoso CR. Rate, pattern and factors related to damage in Brazilian systemic lupus erythematosus patients . Lupus 2003; 12: 788-794 .[Abstract/Free Full Text]
  • Karassa FB, Ioannidis JP, Boki KA, Touloumi G, Argyropoulou MI, Strigaris KA. Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus . Am J Med 2000; 109: 628-634 .[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Mikdashi J, Handwerger B. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort . Rheumatology 2004; 43: 1555-1560 .[Abstract/Free Full Text]
  • Vilá LM, Alarcón GS, McGwin G Jr, Baethge BA, Reveille JD. HLA-class II alleles among two distinct U.S. Hispanic populations with systemic lupus erythematosus. Association with clinical and immunologic manifestations . Arthritis Rheum 2003; 48: S574-S574 (abstract).[CrossRef]
  • Hasan T, Nyberg F, Stephansson Eet al. Photosensitivity in lupus erythematosus, UV photoprovocation results compared with history of photosensitivity and clinical findings . Br J Dermatol 1997; 136: 699-705 .[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Vilá LM, Mayor AM, Valentín AH, Rodríguez SI, Reyes ML, Acosta E, Vilá S. Association of sunlight exposure and photoprotection measures with clinical outcome in systemic lupus erythematosus . P R Health Sci J 1999; 18: 89-94 .[Medline] [Order article via Infotrieve]
  • Alarcón GS, Mc Gwin G Jr, Bastian HMet al. Systemic lupus erythematosus in three groups. VII. Predictors of early mortality in the LUMINA cohort. LUMINA study group . Arthritis Rheum 2001; 45: 191-202 .[CrossRef][ISI][Medline] [Order article via Infotrieve]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 LupusHome page
J. AlSaleh, V. Jassim, M. ElSayed, N. Saleh, and D. Harb
Clinical and immunological manifestations in 151 SLE patients living in Dubai
Lupus, January 1, 2008; 17(1): 62 - 66.
[Abstract] [PDF]

Home page
 Rheumatology (Oxford)Home page
H.-H. Yu, L.-C. Wang, J.-H. Lee, C.-C. Lee, Y.-H. Yang, and B.-L. Chiang
Lymphopenia is associated with neuropsychiatric manifestations and disease activity in paediatric systemic lupus erythematosus patients
Rheumatology, September 1, 2007; 46(9): 1492 - 1494.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vilá, L M
Right arrow Articles by Vilá, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vilá, L M
Right arrow Articles by Vilá, S
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?